Treatment of ocular inflammatory diseases using laquinimod Grant US-11654140-B2 United States of America 23 May 2023
Antibodies directed to IL-17A/IL-17F heterodimers Grant US-10011654-B2 United States of America 03 Jul 2018
Nucleic acid encoding and method of producing anti-IL-17A/IL-17F cross-reactive antibodies Grant US-9650437-B2 United States of America 16 May 2017
Nucleic acids encoding anti-IL-17F antibodies and methods of use thereof Grant US-9475873-B2 United States of America 25 Oct 2016
Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma Grant US-8980832-B2 United States of America 17 Mar 2015
IMMUNE MODULATION Application WO-2014138824-A1 World Intellectual Property Organisation (WIPO) 18 Sep 2014
Methods of treatment using anti-IL-17A/IL-17F cross-reactive antibodies Grant US-8771697-B2 United States of America 08 Jul 2014
Method for the treatment of multiple sclerosis by inhibiting IL-17 activity Grant US-7931900-B2 United States of America 26 Apr 2011
Therapeutic modulation of the tumor inflammatory response Grant US-7871630-B2 United States of America 18 Jan 2011
Therapeutic modulation of the tumor inflammatory response Grant US-7041302-B2 United States of America 09 May 2006